Advocacy intelligence hub — real-time data for patient organizations
National Institute on Drug Abuse (NIDA) — PHASE2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's — EARLY_PHASE1
NYU Langone Health — NA
University of Bern — NA
University of Colorado, Boulder — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Carnitor
(Levocarnitine)Orphan drugstandardLeadiant Biosciences, Inc.
Carnitine Analog [EPC]
Nicholas Ah Mew, MD
Children's National Research Institute
Mamta Fuloria, MD, MD
Montefiore Medical Center
📍 MOUNTAIN LAKES, NJ
Ricardo Cruciani, MD, PhD
Beth Israel Medical Center
Karen L Madsen, MD, MD
Neuromuscular Research Unit, Rigshospitalet
📍 MILWAUKEE, WI
Kathleen Giacomini, PhD
University of California, San Francisco
Chris McIntyre, IDC
London Health Sciences Centre
📍 CAMP LEJEUNE, NC
View all Systemic primary carnitine deficiency specialists →